David Arkowitz - 17 Jun 2022 Form 4 Insider Report for F-star Therapeutics, Inc. (FSTX)

Role
Director
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
Issuer symbol
FSTX
Transactions as of
17 Jun 2022
Transactions value $
$0
Form type
4
Filing time
22 Jun 2022, 17:06:49 UTC
Previous filing
31 Oct 2022
Next filing
06 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FSTX Stock Option Award $0 +20K $0.00 20K 17 Jun 2022 Common Stock 20K $3.41 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted under the Issuer's non-employee director compensation program.
F2 Shares under the award shall vest in 12 equal monthly installments over a one-year period through June 16, 2023, subject to the Reporting Person's continued service as a director of the company.